{
    "nct_id": "NCT03592771",
    "official_title": "Communication App to Manage Symptoms and Improve Adjuvant Endocrine Therapy Adherence",
    "inclusion_criteria": "* Adult female patients (ageâ‰¥18)\n* Diagnosis of ductal carcinoma in situ or Stage I-III hormone receptor-positive breast cancer\n* New prescription for an aromatase inhibitor or tamoxifen\n* Have a mobile device with a data plan or a home computer with Internet\n* Have a valid email address\n* Willing to complete brief surveys on a web-enabled device\n* AET is indicated as standard of care\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 110 Years",
    "exclusion_criteria": "* Unable to communicate in English\n* Prior use of adjuvant endocrine therapy (aromatase inhibitor or tamoxifen) for current diagnosis\n* Concurrently undergoing surgery, chemotherapy or radiation\n* Current diagnosis of rheumatoid arthritis\n* Chronic daily narcotic usage\n* Patient plans to move or transfer their care within the next year",
    "miscellaneous_criteria": ""
}